- Home
- MDXG vs PACB Comparison
MDXG vs PACB Comparison
Compare MDXG & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDXG | PACB |
|---|---|---|
| Founded | 2006 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.6M | 521.8M |
| IPO Year | 2007 | 2010 |
Fundamental Metrics
Financial Performance| Metric | MDXG | PACB |
|---|---|---|
| Price | $4.51 | $1.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $9.00 | $1.67 |
| AVG Volume (30 Days) | 1.1M | ★ 7.6M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $418,630,000.00 | $93,468,000.00 |
| Revenue This Year | N/A | $11.32 |
| Revenue Next Year | $13.02 | $12.14 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.99 | 3.04 |
| 52 Week Low | $3.03 | $1.07 |
| 52 Week High | $7.97 | $2.73 |
Technical Indicators
Market Signals| Indicator | MDXG | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 63.54 | 57.76 |
| Support Level | $4.11 | $1.48 |
| Resistance Level | $5.31 | $1.79 |
| Average True Range (ATR) | 0.15 | 0.10 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 71.09 | 77.78 |
Price Performance
Historical ComparisonAbout MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.